Antifibrotic therapy in scleroderma: extracellular or intracellular targeting of activated fibroblasts?

John Varga*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Antifibrotic therapy in scleroderma: extracellular or intracellular targeting of activated fibroblasts?'. Together they form a unique fingerprint.

Medicine & Life Sciences